Personal information

Other IDs

Scopus Author ID: 7103259103

Keywords

Rheumatology, Systemic Lupus Erythematosus, Clinical Epidemiology, Cardiovascular Disease, Outcomes

Countries

United Kingdom

Activities

Collapse all

Employment (4)

Queen's University Belfast: Belfast, GB

2024-04-08 to present | Pro Vice Chancellor (Faculty of Medicine Health and Life Sciences )
Employment
Source: Self-asserted source
Ian Norman Bruce

University of Manchester: Manchester, GB

2003-08-01 to present | Professor of Rheumatology (Centre for Epidemiology Versus Arthritis)
Employment
Source: Self-asserted source
Ian Norman Bruce

Manchester University NHS Foundation Trust: Manchester, Greater Manchester, GB

1998-10-01 to 2024-04-07 | Honorary Consultant (Kellgren Centre for Rheumatology)
Employment
Source: Self-asserted source
Ian Norman Bruce

Health Innovation Manchester: Manchester, GB

2018-12-01 to 2022-07-31 | Academic Director
Employment
Source: Self-asserted source
Ian Norman Bruce

Education and qualifications (4)

Royal College of Physicians: London, London, GB

2002-02-21 to present | FRCP
Qualification
Source: Self-asserted source
Ian Norman Bruce

Queen's University Belfast: Belfast, Belfast, GB

1995-12-01 to present | Doctor of Medicine (Faculty of Medicine)
Qualification
Source: Self-asserted source
Ian Norman Bruce

Royal College of Physicians: Glasgow, GB

1991-02-01 to present | MRCP
Qualification
Source: Self-asserted source
Ian Norman Bruce

Queen's University Belfast: Belfast, Belfast, GB

1983-10-01 to 1988-06-30 | MB BCh BAO (Faculty of Medicine)
Qualification
Source: Self-asserted source
Ian Norman Bruce

Professional activities (2)

British Society of Rheumatology: Birmingham, GB

2019-05-01 | Heberden Orator
Distinction
Source: Self-asserted source
Ian Norman Bruce

Dalhousie University: Halifax, Nova Scotia, CA

2018-05-08 | JFL Woodbury Lecturer (Rheumatology)
Distinction
Source: Self-asserted source
Ian Norman Bruce

Funding (13)

TLR Blockade in Systemic Autoimmune Rheumatic Diseases

2023-02 to 2024-10 | Grant
Novartis (Switzerland) (Basel, CH)
Source: Self-asserted source
Ian Norman Bruce

BILAG Biologics Register

2023-01 to 2024-08 | Grant
Astra Zeneca (London, GB)
Source: Self-asserted source
Ian Norman Bruce

NIHR Manchester Biomedical Research Centre

2022-12 to 2027-11 | Grant
NIHR (London, GB)
Source: Self-asserted source
Ian Norman Bruce

Manchester LEAP Cohort

2021-12 to 2024-12 | Grant
Janssen (Philadelphia, PA, US)
Source: Self-asserted source
Ian Norman Bruce

SLICC Damage Index Renewal Project

2021-04 to 2025-12 | Grant
Systemic Lupus International Collaborating Clinics (Pittsburgh, PA, US)
Source: Self-asserted source
Ian Norman Bruce

Bioactive Lipid Mediators and Vascular Dysfunction in SLE

2021-03 to 2024-12 | Grant
British Heart Foundation (London, GB)
Source: Self-asserted source
Ian Norman Bruce

EU IMI 3T Consortium

2019-09 to 2026-08 | Grant
European Commission (Brussels, BE)
Source: Self-asserted source
Ian Norman Bruce

NIHR Common Disease BioResource in Immune-Mediated Inflammatory Diseases

2019-01 to 2025-04 | Grant
National Institute for Health Research (London, GB)
Source: Self-asserted source
Ian Norman Bruce

NIHR Senior Investigator

2018-04 to 2021-03 | Grant
National Institute for Health Research (London, GB)
Source: Self-asserted source
Ian Norman Bruce

Immune-Mediated Inflammatory Disease Biobanks in the UK (IMIDBio-UK)

2017-09 to 2021-06 | Grant
Medical Research Council (London, GB)
Source: Self-asserted source
Ian Norman Bruce

NIHR Manchester Biomedical Research Centre

2017-04 to 2022-11 | Grant
National Institute for Health Research (London, GB)
Source: Self-asserted source
Ian Norman Bruce

British Isles Lupus Assessment Group Biologics Register

2017-03 to 2024-08 | Grant
GlaxoSmithKline (London, GB)
Source: Self-asserted source
Ian Norman Bruce

Translational Imaging Methods in Drug Safety Assessment (TRISTAN) Consortium

2017-03 to 2022-02 | Grant
European Commission (Brussels, BE)
Source: Self-asserted source
Ian Norman Bruce

Works (50 of 357)

Items per page:
Page 1 of 8

Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

Annals of the Rheumatic Diseases
2024-11 | Journal article
DOI: 10.1136/ard-2024-225686
Contributors: Cynthia Aranow; Cornelia F Allaart; Zahir Amoura; Ian N Bruce; Patricia C Cagnoli; Walter W Chatham; Kenneth L Clark; Richard Furie; James Groark; Murray B Urowitz et al.
Source: check_circle
Crossref

Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD)

Lupus Science & Medicine
2024-07 | Journal article
DOI: 10.1136/lupus-2024-001213
Contributors: Jessica Ellis; Neil McHugh; John D Pauling; Ian N Bruce; Rachel Charlton; Anita McGrogan; Sarah Skeoch
Source: check_circle
Crossref

Challenges and opportunities in access to care for systemic lupus erythematosus patients across Europe and worldwide

Rheumatology
2024-07-01 | Journal article
DOI: 10.1093/rheumatology/keae227
Contributors: Marta Mosca; Ian N Bruce; Jeanette Andersen; Manuel F Ugarte-Gil; Laurent Arnaud
Source: check_circle
Crossref

Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations

Lupus Science & Medicine
2024-05 | Journal article
DOI: 10.1136/lupus-2023-001124
Contributors: Anca D Askanase; Richard A Furie; Maria Dall'Era; Andrew S Bomback; Andreas Schwarting; Ming-Hui Zhao; Ian N Bruce; Munther Khamashta; Bernie Rubin; Angela Carroll et al.
Source: check_circle
Crossref

A vasculitis mimic during pregnancy: autoimmune progesterone dermatitis

Rheumatology Advances in Practice
2024-03-14 | Journal article
DOI: 10.1093/rap/rkae048
Contributors: Anastasia-Vasiliki Madenidou; Hannah Kither; Ian N Bruce
Source: check_circle
Crossref

Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception Cohort

Lupus
2023-08 | Journal article
DOI: 10.1177/09612033231183273
Contributors: Trixy David; Li Su; Yafeng Cheng; Caroline Gordon; Benjamin Parker; David Isenberg; John A Reynolds; Ian N Bruce
Source: check_circle
Crossref

Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohort

Rheumatology
2023-08-01 | Journal article
DOI: 10.1093/rheumatology/keac680
Contributors: Sarah Dyball; John A Reynolds; Ariane L Herrick; Sahena Haque; Hector Chinoy; Ellen Bruce; Sophia Naz; Ben Parker; Ian N Bruce
Source: check_circle
Crossref

Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trials

Rheumatology
2023-04-03 | Journal article
DOI: 10.1093/rheumatology/keac491
Contributors: Ian N Bruce; Ronald F van Vollenhoven; Eric F Morand; Richard A Furie; Susan Manzi; William B White; Gabriel Abreu; Raj Tummala
Source: check_circle
Crossref

Health inequalities and systemic lupus erythematosus: a global challenge

Rheumatology
2023-03-29 | Journal article
DOI: 10.1093/rheumatology/kead058
Contributors: Ian N Bruce
Source: check_circle
Crossref

Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine

Rheumatology
2023-03-01 | Journal article
DOI: 10.1093/rheumatology/keac372
Contributors: John A Reynolds; Mary Gayed; Munther A Khamashta; Francesca Leone; Veronica Toescu; Ian N Bruce; Ian Giles; Lee-Suan Teh; Neil McHugh; Mohammed Akil et al.
Source: check_circle
Crossref

Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus

Journal of Comparative Effectiveness Research
2023-01 | Journal article
DOI: 10.2217/cer-2022-0192
Contributors: Ian N Bruce; Sarowar Golam; Jason Steenkamp; Pearl Wang; Evelyn Worthington; Barnabas Desta; Konstantina Psachoulia; Wilma Erhardt; Raj Tummala
Source: check_circle
Crossref

Lupus spectrum ambiguity has long-term negative implications for patients

Lupus Science & Medicine
2023-01 | Journal article
DOI: 10.1136/lupus-2022-000856
Contributors: Ian N Bruce; Joy Buie; Lauren Bloch; Sang-Cheol Bae; Karen Costenbader; Roger A Levy; Victoria P Werth; Ashley Marion; Sanjyot Sangodkar; Susan Manzi
Source: check_circle
Crossref

Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials

Lupus Science & Medicine
2023-01 | Journal article
DOI: 10.1136/lupus-2022-000761
Contributors: Ian N Bruce; Ronald F van Vollenhoven; Konstantina Psachoulia; Catharina Lindholm; Emmanuelle Maho; Raj Tummala
Source: check_circle
Crossref

Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance

RMD Open
2022-12 | Journal article
DOI: 10.1136/rmdopen-2022-002593
Contributors: Gwenda Simons; Ellen M Janssen; Jorien Veldwijk; Rachael L DiSantostefano; Matthias Englbrecht; Christine Radawski; Larissa Valor-Méndez; Jennifer H Humphreys; Ian N Bruce; Brett Hauber et al.
Source: check_circle
Crossref

Predicting progression from undifferentiated connective tissue disease to definite connective tissue disease: A systematic review and meta-analysis

Autoimmunity Reviews
2022-11 | Journal article
DOI: 10.1016/j.autrev.2022.103184
Contributors: Sarah Dyball; Mia Rodziewicz; Claudia Mendoza-Pinto; Ian N. Bruce; Ben Parker
Source: check_circle
Crossref

Systemic Lupus Erythematosus Phenotypes Formed from Machine Learning with a Specific Focus on Cognitive Impairment

2022-11-16 | Other
DOI: 10.1093/rheumatology/keac653
Contributors: Michelle Barraclough; Ian Bruce; Jiandong Su; Joan Wither; Patricia Katz; Juan Pablo Diaz-Martinez; Dorcas Beaton; May Choi; Ben Parker; Anna Goldenberg et al.
Source: check_circle
Crossref

Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004 index

Rheumatology
2022-10-06 | Journal article
DOI: 10.1093/rheumatology/keab883
Contributors: Lucy M Carter; Caroline Gordon; Chee-Seng Yee; Ian Bruce; David Isenberg; Sarah Skeoch; Edward M Vital
Source: check_circle
Crossref

The BILAG2004-Pregnancy Index is a valid disease activity outcome measure for pregnant SLE patients

Rheumatology Advances in Practice
2022-09-06 | Journal article
DOI: 10.1093/rap/rkac081
Contributors: Chee-Seng Yee; Munther Khamashta; Mohammed Akil; Rachael Kilding; Ian Giles; David Williams; Ian N Bruce; Caroline Gordon
Source: check_circle
Crossref

Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials

Annals of the Rheumatic Diseases
2022-07 | Journal article
DOI: 10.1136/annrheumdis-2021-221847
Contributors: Ian N Bruce; Richard A Furie; Eric F Morand; Susan Manzi; Yoshiya Tanaka; Kenneth C. Kalunian; Joan T Merrill; Patricia Puzio; Emmanuelle Maho; Christi Kleoudis et al.
Source: check_circle
Crossref

Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus

Journal of Comparative Effectiveness Research
2022-07 | Journal article
DOI: 10.2217/cer-2022-0040
Contributors: Ian N Bruce; Sarowar Golam; Jason Steenkamp; Pearl Wang; Evelyn Worthington; Barnabas Desta; Konstantina Psachoulia; Wilma Erhardt; Raj Tummala
Source: check_circle
Crossref

Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial

Lupus Science & Medicine
2022-05 | Journal article
DOI: 10.1136/lupus-2021-000584
Contributors: Stephen McDonald; Sean Yiu; Li Su; Caroline Gordon; Matt Truman; Laura Lisk; Neil Solomons; Ian N Bruce
Source: check_circle
Crossref

The effects of disease activity, inflammation, depression and cognitive fatigue on resting state fMRI in systemic lupus erythematosus

Rheumatology
2022-04-18 | Journal article
DOI: 10.1093/rheumatology/keab734
Contributors: Michelle Barraclough; Shane McKie; Ben Parker; Rebecca Elliott; Ian N Bruce
Source: check_circle
Crossref

Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria

Lupus Science & Medicine
2022-03 | Journal article
DOI: 10.1136/lupus-2021-000634
Contributors: Ronald van Vollenhoven; Anca D Askanase; Andrew S Bomback; Ian N Bruce; Angela Carroll; Maria Dall'Era; Mark Daniels; Roger A Levy; Andreas Schwarting; Holly A Quasny et al.
Source: check_circle
Crossref

Immune gene expression and functional networks in distinct lupus nephritis classes

Lupus Science & Medicine
2022-01 | Journal article
DOI: 10.1136/lupus-2021-000615
Contributors: Alyssa C Gilmore; Hannah R Wilson; Thomas D Cairns; Marina Botto; Liz Lightstone; Ian N Bruce; Herbert Terence Cook; Matthew Caleb Pickering
Source: check_circle
Crossref

Pregnancy outcomes of a joint obstetric and rheumatology clinic in a tertiary centre: a 2-year retrospective study of 98 pregnancies

Rheumatology Advances in Practice
2022-01-04 | Journal article
DOI: 10.1093/rap/rkac026
Contributors: Ryan Malcolm Hum; Trixy David; Yen June Lau; Hajira Iftikhar; Sue Thornber; Louise Simcox; Ian Bruce; Clare Tower; Pauline Ho
Source: check_circle
Crossref

Accelerated atherosclerosis and cardiovascular disease in systemic lupus erythematosus,Aterosclerosis acelerada y enfermedad cardiovascular en el lupus eritematoso sistémico

Revista Colombiana de Reumatologia
2021 | Journal article
DOI: 10.1016/j.rcreu.2021.03.002
EID:

2-s2.0-85105515026

Part of ISSN: 20279000 01218123
Contributors: Quintana, R.; Pons-Estel, G.J.; Serrano, R.; Pons-Estel, B.A.; Bruce, I.N.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes

Rheumatology (United Kingdom)
2021 | Journal article
DOI: 10.1093/rheumatology/keaa215
EID:

2-s2.0-85090068067

Part of ISSN: 14620332 14620324
Contributors: Monti, S.; Craven, A.; Klersy, C.; Montecucco, C.; Caporali, R.; Watts, R.; Merkel, P.A.; Luqmani, R.; Achilleos, K.; Adler, M. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

BSR guideline on the management of adults with systemic lupus erythematosus (SLE) 2018: Baseline multi-centre audit in the UK

Rheumatology (United Kingdom)
2021 | Journal article
DOI: 10.1093/rheumatology/keaa759
EID:

2-s2.0-85102657586

Part of ISSN: 14620332 14620324
Contributors: Pearce, F.A.; Rutter, M.; Sandhu, R.; Batten, R.L.; Garner, R.; Little, J.; Narayan, N.; Sharp, C.A.; Bruce, I.N.; Erb, N. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Differential levels of IFNα subtypes in autoimmunity and viral infection

Cytokine
2021 | Journal article
DOI: 10.1016/j.cyto.2021.155533
EID:

2-s2.0-85105079089

Part of ISSN: 10960023 10434666
Contributors: Bondet, V.; Rodero, M.P.; Posseme, C.; Bost, P.; Decalf, J.; Haljasmägi, L.; Bekaddour, N.; Rice, G.I.; Upasani, V.; Herbeuval, J.-P. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme

Lupus Science and Medicine
2021 | Journal article
DOI: 10.1136/lupus-2020-000459
EID:

2-s2.0-85101042724

Part of ISSN: 20538790
Contributors: Maslen, T.; Bruce, I.N.; D'cruz, D.; Ianosev, M.; Bass, D.L.; Wilkinson, C.; Roth, D.A.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE-data from the BSR audit of systemic lupus erythematosus

Rheumatology (United Kingdom)
2021 | Journal article
DOI: 10.1093/rheumatology/keaa620
EID:

2-s2.0-85102680039

Part of ISSN: 14620332 14620324
Contributors: Rutter, M.; Lanyon, P.C.; Sandhu, R.; Batten, R.L.; Garner, R.; Little, J.; Narayan, N.; Sharp, C.A.; Bruce, I.N.; Erb, N. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

The Lancet Rheumatology
2021 | Journal article
DOI: 10.1016/S2665-9913(20)30342-8
EID:

2-s2.0-85097387307

Part of ISSN: 26659913
Contributors: Bruce, I.N.; Nami, A.; Schwetje, E.; Pierson, M.E.; Rouse, T.; Chia, Y.L.; Kuruvilla, D.; Abreu, G.; Tummala, R.; Lindholm, C.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey

British Journal of Dermatology
2021 | Journal article
DOI: 10.1111/bjd.19755
EID:

2-s2.0-85102281273

Part of ISSN: 13652133 00070963
Contributors: Mahil, S.K.; Yates, M.; Langan, S.M.; Yiu, Z.Z.N.; Tsakok, T.; Dand, N.; Mason, K.J.; McAteer, H.; Meynell, F.; Coker, B. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research

Lupus Science and Medicine
2021 | Journal article
DOI: 10.1136/lupus-2020-000433
EID:

2-s2.0-85101032745

Part of ISSN: 20538790
Contributors: Tse, K.; Sangodkar, S.; Bloch, L.; Arntsen, K.; Bae, S.-C.; Bruce, I.N.; Connolly-Strong, E.; Costenbader, K.H.; Dickerson, B.; Dörner, T. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

The role of antirheumatics in patients with COVID-19

The Lancet Rheumatology
2021 | Journal article
DOI: 10.1016/S2665-9913(21)00062-X
EID:

2-s2.0-85104323824

Part of ISSN: 26659913
Contributors: Nissen, C.B.; Sciascia, S.; de Andrade, D.; Atsumi, T.; Bruce, I.N.; Cron, R.Q.; Hendricks, O.; Roccatello, D.; Stach, K.; Trunfio, M. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Translating research into clinical practice: Quality improvement to halve non-adherence to methotrexate

Rheumatology (United Kingdom)
2021 | Journal article
DOI: 10.1093/rheumatology/keaa214
EID:

2-s2.0-85100310508

Part of ISSN: 14620332 14620324
Contributors: Barton, A.; Jani, M.; Bundy, C.; Bluett, J.; Mcdonald, S.; Keevil, B.; Dastagir, F.; Aris, M.; Bruce, I.; Ho, P. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Distinct patterns of disease activity over time in patients with active SLE revealed using latent class trajectory models

Arthritis Research & Therapy
2021-12 | Journal article
DOI: 10.1186/s13075-021-02584-x
Contributors: John A. Reynolds; Jennifer Prattley; Nophar Geifman; Mark Lunt; Caroline Gordon; Ian N. Bruce
Source: check_circle
Crossref

Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the PRe-clinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort

Arthritis Research & Therapy
2021-12 | Journal article
DOI: 10.1186/s13075-021-02593-w
Contributors: R. E. Costello; J. H. Humphreys; J. C. Sergeant; M. Haris; F. Stirling; K. Raza; D. van Schaardenburg; Ian N. Bruce
Source: check_circle
Crossref

The effects of disease activity on neuronal and behavioural cognitive processes in systemic lupus erythematosus

Rheumatology
2021-12-24 | Journal article
DOI: 10.1093/rheumatology/keab256
Contributors: Michelle Barraclough; Shane McKie; Ben Parker; Rebecca Elliott; Ian N Bruce
Source: check_circle
Crossref

Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus

Rheumatology
2021-11-03 | Journal article
DOI: 10.1093/rheumatology/keab381
Contributors: Richard A Furie; Ian N Bruce; Thomas Dörner; Manuel Gustavo Leon; Piotr Leszczyński; Murray Urowitz; Birgit Haier; Teri Jimenez; Claire Brittain; Jiajun Liu et al.
Source: check_circle
Crossref

Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004 index

2021-08-05 | Other
DOI: 10.1101/2021.07.30.21261385
Contributors: Lucy M Carter; Caroline Gordon; Chee Seng Yee; Ian Bruce; David Isenberg; Sarah Skeoch; Edward M Vital
Source: check_circle
Crossref

Lupus clinical trial eligibility in a real-world setting: results from the British Isles Lupus Assessment Group-Biologics Register (BILAG-BR)

Lupus Science & Medicine
2021-07 | Journal article
DOI: 10.1136/lupus-2021-000513
Contributors: Sarah Dyball; Sophie Collinson; Emily Sutton; Eoghan M McCarthy; Ian N Bruce; Ben Parker
Source: check_circle
Crossref

Author Correction: Evolving concepts in systemic lupus erythematosus damage assessment

Nature Reviews Rheumatology
2021-06-27 | Journal article
DOI: 10.1038/s41584-021-00620-3
Contributors: Megan R. W. Barber; Sindhu R. Johnson; Dafna D. Gladman; Ann E. Clarke; Ian N. Bruce
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Evolving concepts in systemic lupus erythematosus damage assessment

Nature Reviews Rheumatology
2021-06-15 | Journal article
DOI: 10.1038/s41584-021-00611-4
Contributors: Megan R. W. Barber; Sindhu R. Johnson; Dafna D. Gladman; Ann E. Clarke; Ian N. Bruce
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort

Arthritis and Rheumatology
2020 | Journal article
DOI: 10.1002/art.41392
EID:

2-s2.0-85089782157

Part of ISSN: 23265205 23265191
Contributors: Urowitz, M.B.; Gladman, D.D.; Farewell, V.; Su, J.; Romero-Diaz, J.; Bae, S.-C.; Fortin, P.R.; Sanchez-Guerrero, J.; Clarke, A.E.; Bernatsky, S. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Adverse pregnancy outcomes and subsequent development of connective tissue disease in the UK: an epidemiological study

BJOG: An International Journal of Obstetrics and Gynaecology
2020 | Journal article
DOI: 10.1111/1471-0528.16191
EID:

2-s2.0-85082186323

Part of ISSN: 14710528 14700328
Contributors: Kither, H.; Heazell, A.; Bruce, I.N.; Tower, C.; Crocker, I.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Rheumatology (United Kingdom)
2020 | Journal article
DOI: 10.1093/rheumatology/kez277
EID:

2-s2.0-85080842572

Part of ISSN: 14620332 14620324
Contributors: Chadwick, L.; Kearsley-Fleet, L.; Brown, N.; Maiden, N.; Price, T.; Hopkinson, N.; O'Reilly, S.; Hordon, L.; Griffiths, I.; Porter, D. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Construction of a frailty index as a novel health measure in systemic lupus erythematosus

Journal of Rheumatology
2020 | Journal article
DOI: 10.3899/jrheum.181338
EID:

2-s2.0-85077401794

Part of ISSN: 14992752 0315162X
Contributors: Legge, A.; Kirkland, S.; Rockwood, K.; Andreou, P.; Bae, S.-C.; Gordon, C.; Romero-Diaz, J.; Sanchez-Guerrero, J.; Wallace, D.J.; Bernatsky, S. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts

The Lancet Rheumatology
2020 | Journal article
DOI: 10.1016/S2665-9913(19)30142-0
EID:

2-s2.0-85078479635

Part of ISSN: 26659913
Contributors: Belot, A.; Rice, G.I.; Omarjee, S.O.; Rouchon, Q.; Smith, E.M.D.; Moreews, M.; Tusseau, M.; Frachette, C.; Bournhonesque, R.; Thielens, N. et al.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier

Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE)

Clinical Immunology
2020 | Journal article
DOI: 10.1016/j.clim.2020.108375
EID:

2-s2.0-85083312791

Part of ISSN: 15217035 15216616
Contributors: Donohue, S.J.; Midgley, A.; Davies, J.C.; Wright, R.D.; Bruce, I.; Beresford, M.W.; Hedrich, C.M.
Source: Self-asserted source
Ian Norman Bruce via Scopus - Elsevier
Items per page:
Page 1 of 8
How many people are using ORCID?